Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
A new study reveals how bone marrow stem cell niche generation is regulated, which could lead to improvements in stem cell transplantation for the treatment of blood diseases.
Biomedical engineer Santiago Correa uses his expertise in nanotechnology to create injectable biomaterials that reprogram the body’s immune system to fight cancer, autoimmune disease, and infection.
A new study that uncovers the original role of CRISPR’s scissors answers an evolutionary mystery and could lead to the discovery of better gene editing tools.
A study involving Columbia researchers finds that malaria parasites in Africa have developed resistance to artemisinin drugs, which could worsen malaria’s impact if partner drugs fail in the future.
Health care workers, including registered nurses and support workers, are at increased risk of suicide compared with workers in other fields, Columbia researchers have found.
When all evidence of cancer disappeared from Catherine Spina’s patient after radiation of a single metastasis, she became convinced that radiotherapy may be key to a new treatment approach.
A study led by Columbia obstetricians has shown that a new device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in a wide range of patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
An experimental gel developed by arthritis researchers at Columbia's College of Dental Medicine can reduce osteoarthritis in animals when injected into the joints.